MIAMI, FL / ACCESSWIRE / November 16, 2022 / SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a “Sky Technologies”) (“SKYX,” “we” or “the Company”), a highly disruptive platform technology company with over 60 issued and pending patents globally for simplifying and enhancing safety and automation in homes and buildings, today announced that the American Institute of Architects (“AIA”) has included a SKYX […]

SHELTON, CT / ACCESSWIRE / November 15, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2022 with the Securities and Exchange Commission (SEC) on Monday, November 14, 2022. The report can be accessed at the SEC website […]

BOCA RATON, Fla., Nov. 15, 2022 (GLOBE NEWSWIRE) — Grom Social Enterprises, Inc.’s (NASDAQ: GROM) Curiosity Ink Media announced today that its first activity book based on the wildly popular PAW Patrol® preschool franchise, PAWsome PUPpets!, will debut in the new year, hitting bookshelves everywhere in January 2023. The softcover activity book, brimming with colorful pages featuring […]

Nashville, TN, Nov. 15, 2022 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) – America’s Patriotic Brand (the “Company”) announced its financial results for the three-month period ended September 30, 2022. Investors are encouraged to read the Company’s quarterly report on Form 10-Q, which was filed with the Securities and Exchange Commissions (the “SEC”) […]

DAVIE, FL / ACCESSWIRE / November 15, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological therapeutics and regenerative medicine, is pleased to announce that Mayo Clinic will be the site for clinical trials on Chronic Obstructive Pulmonary Disease (COPD). Mayo Clinic in Phoenix, Arizona will be the […]

TEL AVIV, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today announced it has entered into a letter of intent (“LOI”) with Jeffs’ Brands Ltd (“Jeffs’ Brands”) (Nasdaq: JFBR), […]

MIAMI, FL / ACCESSWIRE / November 14, 2022 / SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a “Sky Technologies”) (“SKYX,” “we” or “the Company”), a highly disruptive platform technology company with over 60 issued and pending patents globally for simplifying and enhancing safety and automation in homes and buildings, today announced that it will host a virtual investor event on […]

Third Quarter Summary Revenues of $99.8 million compared to $24.8 million for the third quarter of 2021; Adjusted EBITDA loss from continuing operations of $14.6 million compared to a loss of $6.3 million in the third quarter of 2021; excluding the results of the renewables segment, adjusted EBITDA for the third quarter of 2022 was a positive $6.0 million; Backlog of $472.3 million as of September 30, […]